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ABSTRACT
Two experiments were conducted to determine the effects of growth hormone (GH) or
melatonin on the reproductive axis of the stallion. In Experiment 1, nine stallions were treated
with GH (20 µg/kg BW) or saline for 21 d starting in January. During the last week of
treatment, stallions were subjected to low and high dose injections of luteinizing hormone (LH),
as well as low and high dose combined injections of gonadotropin releasing hormone (GnRH)
and thyrotropin releasing hormone (TRH). Two months after the onset of GH treatment, semen
was collected from all stallions every other day for 2 weeks. Treatment with recombinant equine
GH increased (P < 0.001) daily IGF-I concentrations, but had no effect (P > 0.1) on
concentrations of LH, follicle stimulating hormone (FSH), or testosterone. The testosterone
responses to injections of LH were similar (P > 0.1) between treatments. Likewise, the LH,
FSH, prolactin, and testosterone responses to the injections of GnRH/TRH were similar (P > 0.1)
between groups. Stallions treated with GH exhibited greater volumes of gel-free semen (P <
0.01) and gel (P < 0.05) and had decreased time until ejaculation (P < 0.05). In Experiment 2,
nine stallions were given corn syrup containing either melatonin (0.06 mg/kg BW) or nothing for
90 d starting in July. Between d 68 and 75 of treatment, stallions were given injections of LH
and combined injections of GnRH and TRH, similar to Experiment I. Semen was collected from
all stallions for three days during the last week of treatment. Treated stallions exhibited
decreased daily concentrations of prolactin (P < 0.01) and FSH (P < 0.05), and tended to have
lower (P = 0.07) LH concentrations for the first 30 d. Testosterone concentrations were similar
between groups. In treated stallions, the low dose administration of GnRH/TRH was not as
effective (P < 0.01) at increasing plasma concentrations of FSH and testosterone, and the
response in plasma prolactin concentrations to a high dose administration of GnRH/TRH was
decreased (P < 0.01). Melatonin treatment did not alter seminal characteristics or libido. In
conclusion, GH may alter the long-term accessory gland contribution to seminal volume, but
does not appear to interact with other constituents of the reproductive axis in the stallion. Longterm melatonin administration decreases plasma concentrations of gonadotropins and prolactin,
vi

but the role of melatonin in perturbation of hypothalamic interaction with the pituitary deserves
further study.
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INTRODUCTION
One of the main goals in equine science is to gain the ability to manipulate reproduction
in the horse. In efforts to better understand equine reproduction, the endocrinology and
predisposing environmental stimuli behind the reproductive cycle of the horse have been
carefully scrutinized. Growth hormone and melatonin are two hormones possibly related to
variations in the reproductive status of the horse.
With the availability of recombinant equine GH, studies were initiated to investigate the
possible role of GH in the reproductive physiology of the horse. Cochran et al. (1999a, b; 2000)
reported that administration of GH increased the number of small follicles on the ovaries of the
cyclic mare, and the combined treatment of seasonally anovulatory mares with a subthreshold
daily GnRH analog treatment resulted in follicular growth to a size that could be induced to
ovulate with human chorionic gonadotropin. One explanation for these observations was that
GH treatment potentiates the ovaries of the mare such that they responded to much lower
gonadotropin concentrations than they normally would, perhaps through increasing the number
of gonadotropin receptors.
Evidence of a relationship between photoperiod and melatonin concentrations created
interest in melatonin as a possible mediator of the reproductive seasonality in the horse. During
the non-breeding season, equine melatonin concentrations are the highest (Guerin et al., 1995),
the stallion exhibits partial testicular atrophy, decreased libido, and decreased accessory fluid
production (Thompson et al., 1977), and the mare becomes anovulatory with decreased levels of
steroids and gonadotropins (Ginther, 1993). Exogenous melatonin administration is reported to
decrease plasma testosterone concentrations in the stallion (Argo et al., 1991) and alter the
chronological events of the breeding season in the mare (Peltier et al., 1997). The following two
experiments were undertaken to assess the effects of GH administration during the nonbreeding
season or melatonin administration through the summer and autumnal transition on the
reproductive axis of the stallion.
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CHAPTER I
REVIEW OF LITERATURE

Hypothalamic-Hypophyseal-Gonadal Axis of the Stallion
Equine reproduction is primarily controlled by the neuroendocrine system, including the
hypothalamus, pituitary, and gonads. This group of organs and their hormonal interactions are
collectively termed the hypothalamic-hypophyseal-gonadal axis (Amann, 1993). The
hypothalamus is responsible for secretion of GnRH, the primary mediator of gonadotropin
secretion. Luteinizing hormone and FSH, the gonadotropins, are generated in the
adenohypophysis (glandular portion of the pituitary gland). The hypophyseal-portal system is
the anatomical section of the circulatory system that links the hypothalamus and the pituitary
gland and transmits their products into the peripheral circulation. Gonadotropins interact with
the testes in the male to control androgen production and secretion as well as spermatogenesis.
Equilibrium of the male reproductive system is maintained through the negative feedback of
steroids, predominately testosterone, on the hypothalamus and pituitary (Amann, 1993; Hadley,
2000).
Gonadotropin Releasing Hormone. Gonadotropin releasing hormone is a decapeptide
produced in and secreted by neurons of the hypothalamus. Once termed luteinizing hormone
releasing hormone for its effects on LH secretion, it was found also to modify FSH secretion and
has since been referred to as GnRH. It has an approximate half-life in the peripheral blood
stream of 30 min, however this figure can vary with the amount of albumin binding that occurs
in circulation (Irvine and Alexander, 1993a).
Patterns of secretion for GnRH have been difficult to study due to its highly diluted
circulating levels. Peripheral plasma GnRH levels exist in immeasurable subfemtomolar
concentrations, and the only measurable concentrations of GnRH are located in the median
eminence of the hypothalamus. Push-pull perfusion of the mediobasal hypothalamus, a method
of extracting small amounts of hypothalamic venous effluent, has been one effective means for
2

the study of GnRH secretory patterns (Irvine and Alexander, 1993a). Sharp and Grubaugh
(1987), as well as Irvine and Alexander (1991), developed facial vein catheterization methods for
sampling hypothalamic venous effluent in the horse. Sharp and Grubaugh (1987) reported
GnRH pulse frequency is irregularly episodic with the most infrequent secretion occurring
during periods of reproductive quiescence. Moreover, Irvine and Alexander (1991) reported
breeding season GnRH secretion is continuous with superimposed pulses occurring up to twice
hourly.
Immunization against GnRH, as well as treatment with GnRH or analogs, has helped to
expand the understanding of how GnRH affects gonadotropin concentrations. Immunization
against GnRH has been proven to lower plasma gonadotropin concentrations (Schanbacher,
1984; Garza et al., 1986). Garcia and Ginther (1975) reported that constant infusion of mares
with GnRH over a 24-h period induces a steady increase in LH concentrations. In addition,
pulsatile administration of GnRH (Blue et al., 1991) and implantation of GnRH agonists (Boyle
et al., 1991) have elevated plasma LH concentrations in stallions. Administration of GnRH to
stallions has also elicited responses in FSH and variable responses in testosterone indirectly
through LH (Seamans et al., 1991; Blue et al., 1991). Furthermore, the frequency of GnRH
pulses seems to be important in regulating the proportions of gonadotropins released in the mare.
Gonadotropin releasing hormone pulses every 45 min seem to favor LH secretion, yet pulses
every 6 h causes increased secretion of FSH (Turner and Irvine, 1991).
Luteinizing Hormone and Follicle Stimulating Hormone. The gonadotropins, LH and
FSH, are glycoproteins secreted by the gonadotrope cells of the adenohypophysis. The two
hormones each have an approximate molecular weight of 34,000 (Braselton and McShan, 1970).
Gonadotropins consist of a species specific α subunit and a biologically active β subunit (Pierce
and Parsons, 1981). Secretion of gonadotropins is generally pulsatile in nature and is primarily
controlled by GnRH stimulation. The role of the gonadotropins is to stimulate steroid and
gamete production in both the male and female (Irvine and Alexander, 1993b).
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The two gonadotropins play separate roles in the regulation of male reproduction.
Follicle stimulating hormone affects Sertoli cell function and inhibin production. Also, FSH
functions along with LH-induced testosterone secretion to initiate and maintain spermatogenesis.
In contrast, LH controls production and secretion of steroids by the Leydig cells and
subsequently the development of secondary sex characteristics. Moreover, FSH acts
synergistically with LH to increase testosterone production (Hadley, 2000).
Regulation of gonadotropin secretion is accomplished through the stimulation of GnRH
and the negative feedback of hormones secreted from the testes. Individual gonadotropin
responses to hypothalamic GnRH pulses allow for differences in LH and FSH plasma
concentrations (Hadley, 2000). Surges in plasma concentrations of LH, as opposed to FSH,
seem more often to be concurrent with GnRH pulses in the stallion (Thompson et al., 1985).
Dissimilar patterns of FSH and LH concentrations may result from three distinct types of
gonadotrope cells characterized in the equine pituitary (Rahmanian et al., 1998). Also, while
plasma concentrations of both gonadotropins are decreased by a tonic inhibitory steroid feedback
at the pituitary and hypothalamus, FSH concentrations are altered at the pituitary by inhibin and
activin as well (Irvine and Alexander, 1993b).
In the mare, plasma LH and FSH concentrations follow a seasonal pattern with maximal
concentrations occurring in waves during the steroid induced cyclic reproductive season
(Freedman et al., 1979; Garcia and Ginther, 1979). In the stallion, plasma LH and FSH
concentrations rise with the advent of the breeding season, and begin to fall again as the winter
months approach (Irvine and Alexander, 1982; Johnson and Thompson, 1983). Patterns of
secretion of LH and FSH in the stallion are generally not pulsatile and are tightly coupled to one
another (Thompson et al., 1985).
Testosterone. Testosterone is responsible for male sexual characteristics, accessory sex
gland function, and synergistic maintenance of spermatogenesis with FSH (Amann, 1993). In
the stallion, steroid hormones are primarily produced by the Leydig cells of the testicular
interstitium. These steroids include testosterone, progesterone, estradiol, and their derivatives.
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The precursor to steroids is cholesterol. In the male, cholesterol is converted to pregnenolone by
the Leydig cells of the testes. Subsequently, testosterone is derived from pregnenolone by either
the delta 4 or delta 5 steroid pathway. Luteinizing hormone stimulates steroidogenesis by the
Leydig cells (Amann, 1993). The possible mechanism of LH stimulation of testosterone is the
increased synthesis of pregnenolone from cholesterol (Hadley, 2000). Plasma testosterone
concentrations in the stallion vary according to seasonal reproductive state. Thus, plasma
testosterone concentrations are higher in the summer and lower in the winter (Johnson and
Thompson, 1983). Variations in concentrations of testosterone in the stallion are reported to be
episodic and are not consistently exhibited with pulses in LH concentrations (Thompson et al.,
1985).
Seminal and Testicular Characteristics
Seminal evaluation can be an effective method of measuring reproductive competence in
the stallion. Evaluation of trends in volume, concentration, and sperm motility of semen and
associating these trends with changes in endocrine patterns have expanded the understanding of
stallion reproductive physiology. The stallion is a seasonal breeder exhibiting changes in
seminal characteristics over the course of the year. Reproductive capacity in stallions is greatest
during the summer and diminished during the winter months (Pickett et al., 1976; Thompson et
al., 1977; Clay et al., 1987). Leydig and Sertoli cell numbers and testosterone concentration of
the equine testes are greatest during the breeding season (Johnson and Thompson, 1983, 1987).
Consequently, mean volumes of gel-free semen and gel (Thompson et al., 1977) and number of
spermatozoa per ejaculate (Pickett et al., 1976) are greatest in the summer in correlation with the
breeding season of the mare.
Some seminal characteristics can be manipulated by an artificial photoperiod. An
increasing artificial photoperiod imposed during the winter months resulted in decreased gel-free
semen and increased spermatozoa per volume of gel-free semen, but no effect was seen on
number spermatozoa per ejaculate or percentage of motile spermatozoa (Thompson et al., 1977).
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Others have reported increases in sperm output and total scrotal width in response to an
increased artificial photoperiod during the winter months (Clay et al., 1987)
Factors other than season affect seminal characteristics. Increased total scrotal width is
correlated with an increase in daily sperm output (Thompson et al., 1979). Seminal volume,
largely the product of accessory sex glands, and total scrotal width tend to increase with age.
Conversely, concentration and sperm motility seem to remain similar with increased age (Amann
et al., 1979). Sexual arousal has also been reported to increase gel-free seminal volume
(Thomson et al., 1996).
Growth Hormone
Growth hormone (GH) is a protein consisting of 191 amino acids and is secreted by the
somatotrope cells of the adenohypophysis (Hadley, 2000). Plasma GH concentrations analyzed
in the horse are episodic in nature with no diurnal patterns (Thompson et al., 1992; Stewart et al.,
1993). Concentrations of GH have been reported to increase upon refeeding after fasting (Nadal
et al., 1997), after feed restriction (Sticker et al., 1995), and after acute exercise (Thompson et
al., 1994). Administration of recombinant equine GH to the horse results in hyperglycemia,
hyperinsulinemia, insulin insensitivity, and mobilization of fatty acids (Smith et al., 1999).
Deficiency of GH production in young growing animals results in dwarfism. Conversely,
hypersecretion of GH occurring early in life results in gigantism. Acromegaly occurs with
hypersecretion of GH in mature animals (Hadley, 2000). Secretion of GH from the pituitary is
inhibited by somatostatin and stimulated by GH releasing hormone (Hadely, 2000). Growth
hormone response to GH releasing hormone administration has been reported in the horse
(Thompson et al., 1994). These regulatory hormones are generated in the hypothalamus.
Somatostatin is released in response to negative feed back by high levels of insulin-like growth
factor I (IGF-I; Hadley, 2000). Furthermore, chronic administration of GH in the horse inhibits
the endogenous GH response to secretagogue (Smith et al., 1999).
Many physiological effects of GH are carried out indirectly through somatomedin
secretion by the liver (Hadley, 2000). Insulin-like growth factor-I is the prime somatomedin of
6

study. Growth hormone and IGF-I play a role in gonadal function of various species. Growth
hormone deficient humans and those immunized against GH have experienced delayed puberty
and lack of response to human chorionic gonadotropin. In contrast, GH deficient children have
experienced accelerated pubertal maturation after GH treatment (Kulin et al., 1981). Similarly,
immunization of heifers against GH releasing factor results in delayed puberty (Cohick et al.,
1996). In dwarf mice, GH deficiency prevents full differentiation of Leydig and Sertoli cells
(Hochereau-de Reviers et al., 1987). Growth hormone and IGF-I receptors have been identified
in the Leydig and Sertoli cells of rat testes (Smith et al., 1987). In addition, elevated IGF-I levels
have been linked to increased steriodogenesis in response to LH in mice (Chatelain et al., 1991).
Mediation of testicular response to LH is attributed to GH in humans (Kulin et al., 1981) and
experimental mice (Chatelain et al., 1991).
When recombinant equine GH became available, studies were conducted on the
reproductive effects of GH administration to horses. Cochran et al. (1999b) reported that
administration of recombinant equine GH increased the number of small follicles on the ovaries
of the cyclic mare. Similarly, treatment of seasonally anovulatory mares with GH resulted in an
increased number of small follicles not large enough to ovulate (Cochran et al., 1999a).
However, the combined treatment of seasonally anovulatory mares with a GH and subthreshold
daily GnRH analog treatment (Cochran et al., 2000) resulted in follicular growth to a size that
could be induced to ovulate with human chorionic gonadotropin. Hence, GH treatment possibly
potentiates the ovaries of seasonally anovulatory mares allowing an ovarian response to much
lower gonadotropin concentrations than normal. One explanation for such a response is the upregulation (increase in number) of gonadotropin receptors on the ovaries.
Photoperiod and Melatonin
Photoperiod. In a variety of species, reproduction is physiologically confined to a certain
period of the year to ensure that the progeny will be born during optimum environmental
conditions. Long day breeders including the hamster, brown bear, and horse experience
diminished reproductive capacity during the decreased photoperiod of the winter months,
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whereas, short day breeders, such as the sheep, are positively affected during the same period
(Gerlach and Aurich, 2000). The predominating environmental factor regulating seasonal trends
in reproduction is photoperiod in both long and short day breeders alike (Gerlach and Aurich,
2000).
The horse exhibits increased reproductive capacity during the summer in response to
increased photoperiod. Sharp and Ginther (1975) exposed pony mares to either prevailing
photoperiod from October to February or an artificial photoperiod equivalent to transition from
March to July. Mares under increasing photoperiod exhibited increased number and size of
follicles when compared to those under ambient conditions. This hastening of the onset of the
ovulatory season in response to an artificially increased photoperiod has been consistently
reported (Kooistra and Ginther, 1975; Freedman et al., 1979). The stallion also exhibits seasonal
changes with increased total scrotal width and sexual behavior (Clay and Clay, 1992).
Response to photoperiod is also reflected by the patterns in hormonal secretion over the
duration of the year. In the stallion, plasma LH concentrations rise at the advent of the breeding
season, and begin to fall again as the winter months approach (Irvine and Alexander, 1982;
Johnson and Thompson, 1983). Stallions under an artificial photoperiod of increasing daylight
during the winter months experienced an accelerated seasonal increase in LH concentrations and
increased plasma testosterone concentrations (Thompson et al., 1977). Likewise, mares exhibit
increased plasma LH concentrations during the spring and summer (Freedman et al., 1979), and
similar to the stallion, mares exposed to constant light for 28 d during the winter experienced
increased daily plasma LH concentrations (Cleaver et al., 1991). Annual profiles of plasma FSH
and testosterone concentrations in the stallion fluctuate similarly to those of LH but with smaller
magnitude of change (Clay and Clay, 1992).
Photorefractoriness plays a role in the seasonal changes in the equine reproductive state.
Clay and Clay (1992) give a good description of the photorefractoriness in the stallion. Stallions
chronically exposed to an increased artificial photoperiod during the winter initially respond with
a short-term testicular recrudescence, but then become refractory and return to the state of
8

untreated stallions. This implies that premature induction of sexual recrudescence results in a
premature reproductive quiescence, or perhaps, photorefractoriness is the cause for normal
regression at the advent of autumnal transition. Thus, the short days at the onset of winter may
not be the stimulus for autumnal regression, but perhaps a period of lessened photostimulation in
which stallions regain sensitivity to long days.
Melatonin. Melatonin, an indole amine, was first isolated from bovine pineal tissue and
is secreted by the pineal gland of nearly all mammals (Reiter, 1981; Grubaugh et al., 1982;
Gerlach and Aurich, 2000). Melatonin secretion by the equine pineal gland was determined to
be circadian in nature with elevated levels occurring during the night (Kilmer, 1982; Guerin et
al., 1995). In addition, the release of melatonin from the pineal gland is negatively influenced by
photoperiod in rats (Quay, 1963; Wurtman et al., 1964), sheep (Rollag and Niswender, 1976;
Karsch et al., 1986), and cattle (Sanchez-Barcelo et al., 1991). Melatonin secretion, therefore,
provides a physiological unambiguous circannular rhythm with longest periods of secretion in
the winter (long nights) and shortest periods of secretion in the summer (short nights).
Synthesis of melatonin in the mammalian pineal gland is the result of the precursor
tryptophan being converted to serotonin and then to melatonin through a series of steps. Two
enzymes involved in melatonin synthesis are hydroxyindole-O-methyl-transferase and the ratelimiting factor, N-acetyltransferase (Reiter, 1981). Hydroxyindole-O-methyl-transferase activity
in the horse is highest in the fall and winter and lowest during the spring and summer. In
addition, the percentage of ovulatory mares is inversely related to the amount of hydroxyindoleO-methyl-transferase activity (Wesson et al., 1979).
Reiter (1981) describes the route of innervation for photoregulation of the pineal gland.
As light strikes the retina of the eye, a neural signal travels via the optic nerves to the
suprachiasmatic nuclei. Optic nerves synapse with neurons of the suprachiasmatic nuclei leading
to superior cervical ganglia. Finally, melatonin secretion by the mammalian pineal gland is
inhibited by the post-ganglionic neurons diverging from the superior cervical ganglia.
Interrupting this pathway through bilateral superior cervical ganglionectomy of pony mares
9

during winter anestrus results in delay of the second ovulatory season (Sharp et al., 1979). This
is consistent with the “zeitgeber” phenomenon of free-running rhythm after the loss of an
environmental time-keeping factor (Sharp and Cleaver, 1993). Similarly, pinealectomy of mares
resulted in delay of the first ovulation for the second post-operative season and abolished the
response to a stimulatory artificial photoperiod (Grubagh et al., 1982). Thus, the effect of
melatonin on the reproductive axis may be to synchronize the endogenous physiological status of
the horse to changes in photoperiod.
Short-day breeders, such as sheep, exhibit an increase in reproductive capacity in
response to melatonin administration. Luteinizing hormone, FSH, and testicular function have
been reported to increase in response to melatonin treatment in the ram (Lincoln and Maeda,
1992). Pinealectomized ewes treated with a short-day regimen of melatonin exhibit an initial
increase in plasma LH concentrations (Karsch et al., 1986). Also, melatonin administration
advances the onset of cyclic activity in lambs (Nowak et al., 1990).
Administration of melatonin to long-day breeders in a manner that mimics short days
results in adverse effects on sexual competence. In the hamster, melatonin administration
induces regression of the testes (Carter and Goldman, 1983) and suppresses plasma LH
concentrations (Reiter, 1981). Similarly, the mare experiences a delay of first ovulation of the
year after melatonin treatment (Guillaume and Palmer, 1991). Furthermore, exogenous
melatonin administration decreased plasma testosterone concentrations in the stallion (Argo et
al., 1991) and altered the chronologic events of the breeding season in the mare (Peltier et al.,
1998). Plasma melatonin concentrations in ovariectomized pony mares under constant light
initially decrease (Cleaver et al., 1991). Accordingly, melatonin administration to mares has
been reported to decrease plasma prolactin concentrations (Aurich et al., 1997; Fitzgerald et al.,
2000). Thus, a possible suppression of gonadotropin activity may be attributed to periods of
increased melatonin secretion in the horse.
Receptors for melatonin have been characterized in the hypothalamus and pituitary of the
rabbit, sheep (Stankov et al., 1991), cattle, donkey (Nonno at el., 1995), and horse (Stankov et
10

al., 1991; Nonno at el., 1995). With only slight differences between species, minute melatonin
receptor concentrations exist in the mediobasal portion of the hypothalamus and increase in
number distally to the pars tuberalis, pars distalis, and pars intermedia. The location of
melatonin receptors in the hypothalamus is coincident with the equine median eminence, the area
of highest GnRH concentrations (Strauss et al., 1979; Cleaver et al., 1991). In addition, the pars
distalis is the location of equine gonadotrope cells (Rhamanian et al., 1998). The localization of
melatonin receptors in the proximity of the hypothalamic-hypophyseal axis points to a possible
interaction of melatonin in regulation of reproduction.
Prolactin
Prolactin is a 199 amino acid protein very similar in composition to GH, with an
approximate molecular weight of 25,000, and is produced in the lactotropes of the
adenohypophysis (Hadley, 2000). Equine prolactin secretion is reported as episodic in nature
(Roser et al., 1987). In the horse, plasma prolactin concentrations increase in late pregnancy
(Ginther, 1993) and are highest during the breeding season; they fall in winter and are correlated
with both photoperiod and temperature (Johnson, 1986; Thompson and Johnson, 1987).
However, increasing the photoperiod during the winter reproductive quiescence hastens the onset
of high summer prolactin concentrations (Johnson, 1987). Plasma prolactin concentrations have
also been reported to increase with age in horses (Thompson and Johnson, 1987).
Effects on a variety of physiological functions have been attributed to prolactin. In
certain species, prolactin exhibits tropic effects on mammary glands, sebaceous glands, luteal
tissue, and pelage (Hadley, 2000). Prolactin is likely responsible for light- and temperatureinduced hair shedding in the horse (Kooistra and Ginther, 1975; Sharp and Ginther, 1975;
Thompson et al., 1997) and in the sheep (Lincoln and Tortonese, 1995). Also, plasma prolactin
concentrations have been reported to increase with feeding (Sticker et al., 1995; Nadal et al;
1997), exercise, stress (Colborn et al., 1991a,b), and sexual stimulation (Colborn et al., 1991a,b;
Thomson et al., 1996).
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Regulation of prolactin secretion is achieved through inhibition by dopamine from the
hypothalamus (Hadely, 2000). In the horse, administration of dopamine antagonists increase
plasma prolactin concentrations (Colborn et al., 1991b; Nequin et al., 1993), and dopamine
agonists exert inhibitory effects on prolactin concentrations (Thomson et al., 1996). Dopamine
pathways have also been reported to be involved in prolactin synthesis in the ram (Lincoln and
Tortonese, 1995). Though the existence of a true prolactin releasing hormone has not been
elucidated, TRH has been reported to increase plasma prolactin concentrations (Johnson, 1986;
1987; Colborn et al., 1991b; Gentry et al., 2002). The response of prolactin to TRH
administration is affected by season, with greater responses occurring in the summer (Johnson,
1987). In addition, TRH has been reported to bind directly to receptors on the lactotrope cells
(Gerschengorn et al., 1979).
Prolactin may be a melatonin-mediated regulator of reproductive competence in seasonal
species. Melatonin implants in the mediobasal hypothalamus of the ram caused a significant
increase in prolactin (Lincoln and Maeda, 1992). Prolactin was also reported to increase in
correlation with increased follicular activity and increased plasma LH concentrations in the mare
(Nequin et al., 1993). Prolactin concentrations are significantly lower during the non-breeding
season, the duration of highest plasma melatonin concentrations, than during the breeding season
of the horse (Thompson et al., 1986; 1987). Nequin et al. (1993) reported that administration of
a dopamine antagonist or exogenous prolactin during anestrus increased follicular activity on the
ovaries of mares. Correspondingly, melatonin administration to mares decreases plasma
prolactin concentrations during the reproductive season (Aurich et al., 1997; Fitzgerald et al.,
2000), though the prolactin response to melatonin administration may be less sensitive during the
winter (Fitzgerald et al., 2000).
Rationale for Present Experiments
The effects of GH on reproduction are apparent in various mammalian species (Kulin et
al., 1981; Chatelain et al., 1991; Cohick et al., 1996). However, there is a lack of information on
the effects of GH administration on reproduction in the horse. Recently, with the availability of
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equine somatotropin, research endeavors have been undertaken to assess the role of GH in
equine reproduction. Studies previously conducted in mares (Cochran et al., 1999a, b; 2000)
indicated that GH administration increased the number of small ovarian follicles in cycling and
anovulatory mares, and possibly increased ovarian sensitivity to gonadotropins. Given the nature
of effects resulting from GH administration in the mare, a similar testicular response to GH is
plausible.
Melatonin is another hormone implicated as a mediator of reproduction in the horse
(Argo et al., 1991; Aurich et al., 1997; Peltier et al., 1997). Exogenous melatonin administration
is reported to decrease plasma testosterone concentrations in the stallion (Argo et al., 1991) and
alter the chronologic events of the breeding season in the mare (Peltier et al., 1997). Melatonin
administration to mares has also been reported to decrease plasma prolactin concentrations
(Aurich et al., 1997; Fitzgerald et al., 2000). As with GH administration, studies concerning the
effects of melatonin administration on the reproductive function in the stallion are lacking.
Given the nature of GH and melatonin as mediators of reproductive function, the
following two experiments were undertaken to assess the effects of GH administration during the
non-breeding season or melatonin administration through the summer and autumnal transition on
reproduction related hormonal and seminal characteristics of the stallion.
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CHAPTER II
EFFECTS OF GROWTH HORMONE TREATMENT ON HORMONAL AND SEMINAL
CHARACTERISTICS IN STALLIONS

Introduction
Growth hormone is reported to alter the reproductive physiology of humans (Kulin et al.,
1981), mice (Chatelain et al., 1991), and cattle (Cohick et al., 1996), and with the availability of
recombinant equine GH, understanding of the effects of GH administration on equine
reproduction is currently developing. Cochran et al. (1999b) reported that administration of
recombinant equine GH increased the number of small follicles on the ovaries of the cyclic mare.
Similar treatment of seasonally anovulatory mares resulted in an increase in number of small
follicles (Cochran et al., 1999a) but did not result in follicles large enough to ovulate. However,
the combined treatment of seasonally anovulatory mares with a subthreshold daily GnRH analog
treatment (Gentry et al., 1999) and GH resulted in follicular growth to a size that could be
induced to ovulate with human chorionic gonadotropin (Cochran et al., 2000). One explanation
for this latter observation was that the GH treatment potentiated the ovary of the seasonally
anovulatory mares such that they responded to much lower gonadotropin concentrations than
they normally would, perhaps via increasing the number of gonadotropin receptors on the ovary.
The purpose of this experiment was to determine if similar daily GH administration to stallions
would increase the testosterone response to a minimal dose of LH and to assess the subsequent
effects of combined injections of GnRH and TRH.
Materials and Methods
Nine adult, light horse stallions were maintained in similar outdoor paddocks and fed
daily hay and grain rations. Stallions were randomly assigned to GH-treated (n = 5) or control (n
= 4) groups. Growth hormone-treated stallions were administered recombinant equine GH
(BresaGen, Ltd., Adelaide, Australia) at 20 µg/kg BW as an i.m. injection daily for 21 d
beginning in January and control stallions were administered saline in a similar manner. Blood
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was collected via jugular venipuncture into heperanized tubes every 48 h at dawn prior to daily
injections. On d 15 of GH treatment, frequent (every 30 min) blood samples were collected via
indwelling jugular catheters from all stallions for a 6-h period following the daily treatments to
assess the resting plasma concentrations of LH, FSH, and testosterone. Immediately after the 6-h
sample was drawn, all stallions were administered a standard, “low” dose LH injection (0.2 µg
LH/kg BW i.v.) to assess the testosterone responsiveness of the testes. The dose of LH used was
determined in preliminary trials to produce an LH rise similar to naturally occurring, endogenous
rises in stallions. On d 17 of treatment, a low dose GnRH/TRH combination (0.1 µg GnRH and
0.4 µg TRH/kg BW i.v.) was administered to all stallions to assess the pituitary responsiveness
to these secretagogues. Subsequently, a high dose of LH (0.3 µg LH/kg BW i.v.) and a high
dose GnRH/TRH combination (1.0 µg GnRH and 4.0 µg TRH/kg BW i.v.) were administered on
d 19 and 21, respectively. Frequent blood sampling was conducted via indwelling jugular
catheters around all secretagogue injections at –15, 0, 5, 10, 20, 30, 60, 90,120,150, 180, 210,
and 240 min relative to treatment.
Blood collected during frequent and daily sampling was immediately centrifuged, and
plasma was harvested and stored at -15°C until assay. All samples were analyzed by
radioimmunoassay as previously described for LH (Thompson et al., 1983a), FSH (Thompson et
al., 1983b), prolactin (Colborn et al., 1991), and testosterone (Diagnostic Systems Laboratories,
Webster, TX). Daily blood samples were also analyzed for IGF-I (Sticker et al., 1995) and GH
(Thompson et al., 1992) concentrations.
Two months after the onset of GH treatment, semen was collected from all stallions by
means of an artificial vagina every 2 d for 2 weeks. Each collection was evaluated for length of
time from arousal until ejaculation, number of mounts per ejaculate, gel-free seminal volume,
volume of gel, concentration of spermatozoa per ejaculate, total spermatozoa per ejaculate,
motility, and morphology (percentages of live/dead, normal, head abnormalities, tail
abnormalities, mid-piece abnormalities, protoplasmic droplets).
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Data were analyzed using the GLM procedures of SAS (SAS Inst. Inc., Cary, NC).
Daily hormonal concentrations were analyzed by split-plot ANOVA (Gill and Hafs, 1971) for
the effects of treatment, day, and treatment by day interactions. Hormonal concentration data
from the period of frequent sampling and around the challenges were analyzed by ANOVA (Gill
and Hafs, 1971) for the effects of treatment, minute, and treatment by minute interactions. Data
at the seminal collections were also evaluated by split-plot ANOVA (Gill and Hafs, 1971) for the
effects of treatment, day, and treatment by day interactions.
Results
Hormonal Data. Treatment with recombinant equine GH increased (P < 0.001) plasma
IGF-I concentrations in samples collected every 48 h; plasma GH concentrations in the same
samples were similar (P > 0.1) for the two groups through d 13, but diverged thereafter (Figure
2.1). Also, no treatment effect (P > 0.1) was observed for concentrations of testosterone in 48 h
blood samples or during frequent blood collections on d 15 (Figure 2.2). Similarly, basal
concentrations of LH and FSH during the period of frequent sampling on d 15 were not affected
(P > 0.1) by treatment, however, treated stallions had greater (P > 0.001) GH concentrations for
the duration of the sampling period (Figure 2.3). Furthermore, the testosterone concentrations in
samples collected around both the low and high doses of LH and GnRH were virtually identical
(P > 0.1) for the two groups of stallions (Figure 2.4), although testosterone concentrations for
both groups increased over time (P < 0.001) in response to secretagogue administration.
Likewise, the LH, FSH, and prolactin responses to combined GnRH and TRH administration at
both the low and high doses, on d 17 (Figure 2.5) and d 21 (Figure 2.6) respectively, increased
over time (P < 0.001) but were not different (P > 0.1) between groups.
Seminal Data. When semen was collected from these stallions 2 months later, GHtreated stallions had higher (P < 0.001) volume of gel-free semen, higher (P < 0.05) volume of
gel, and decreased (P < 0.05) time until ejaculation; no other differences (P > 0.05) between
groups were observed (Table 2.1).
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Figure 2.1. Mean plasma concentrations of GH and IGF-I for samples collected every 48 hr in
response to daily GH (GH-treated) or saline (Control) administration. There was a main effect of
treatment (P < 0.001) as well as a treatment by time interaction (P < 0.001) for plasma
concentrations of IGF-I. The least significant difference (LSD) for comparison of means is
indicated by the vertical bar.
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Figure 2.2. Mean plasma concentrations of testosterone for every 48 hr blood sampling and
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No effect (P > 0.1) of treatment was observed. The least significant difference (LSD) for
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Figure 2.3. Mean plasma concentrations of FSH, LH, and GH during frequent blood sampling
on d 15 after daily treatment with GH (GH-treated) or saline (Control). There was a main effect
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Table 2.1 Semen collection data for control and GH-treated stallions expressed as
mean ± SEM.
Control
GH
Number of Mounts

1.3 +/- 0.28

1.5 +/- 0.25

Gel-Free Volume, ml*

83.1 +/- 7.3

37.4 +/- 6.6

Gel Volume, ml*

20.1 +/- 6.4

2.7 +/- 5.7

Concentration, millions/ml

140 +/- 35.4

270 +/- 31.6

Total Sperm/Ejaculate,
billions
Motility, %

11.2 +/- 2.0

8.4 +/- 1.8

61.7 +/- 8.2

60.5 +/- 7.36

Ejaculation Time, min*

2.5 +/- 1.1

5.1 +/- 0.9

Live spermatozoa, %

85.4 +/- 2.9

84.1 +/- 2.6

Normal spermatozoa, %

72 +/- 3.6

70.35 +/- 3.2

Head Abnormalities, %

13.96 +/- 2.8

13 +/- 2.5

Tail Abnormalities, %

8.4 +/- 2.0

10.9 +/- 1.8

Midpiece Abnormalities, %

4.72 +/- 1.8

4.8 +/- 1.6

Distal Droplet, %

0.92 +/- 0.8

0.95 +/- 0.7

Characteristics with superscript (*) differ (P < 0.05) between treatments.
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Discussion
As in previous experiments (Cochran et al., 1999b; Smith et al., 1999), administration of
equine GH increased daily plasma IGF-I concentrations in treated stallions, confirming the
biological activity of the injected hormone. Also, frequent sampling on d 15, subsequent to daily
GH administration, verified the maintenance of high levels of GH for a minimum of 6 h after
injection. These elevated plasma GH concentrations returned to levels of controls by the
following 48 h sample, demonstrated by the similar plasma concentrations in daily samples.
However, in spite of high circulating levels of IGF-I and GH in treated stallions, plasma
testosterone concentrations in samples collected every 48 h were similar to those of controls.
All stallions exhibited testosterone responses to the low and high doses of LH used in the
challenges on d 15 and 19, however no alteration in response was observed due to previous GH
treatment. If the number of LH receptors in the testes had been increased by GH treatment, a
greater sensitivity of the testis to the small LH challenge (i.e., more testosterone secreted) would
have been expected. The similar response in plasma testosterone concentrations indicates that
there was likely no alteration in testis sensitivity, thus no alteration in LH receptor numbers.
Certainly other explanations exist, and direct measurement of LH receptor content in the testes
would better test the receptor-number hypothesis. These results in stallions differ from the
results of others studying dwarf mice (Chatelain et al., 1991) and prepubertal boys (Kulin et al.,
1981), in which treatment with GH or IGF-I resulted in an increase in the testosterone response
to human chorionic gonadotropin. The low dose injection of LH in the current experiment was
devised to avoid the possibility of “overwhelming” the testes with higher doses of LH or human
chorionic gonadotropin commonly used in diagnostic testing in stallions.
In addition to the lack of perturbation of testosterone response to LH, there was no
alteration in the LH or FSH response to GnRH in either challenge due to GH treatment or in the
basal concentrations of LH, FSH, and testosterone during the period of frequent sampling.
Thus, exogenous GH treatment does not appear to alter the pituitary sensitivity to GnRH during
the stallion nonbreeding season.
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Exogenous GH has been reported to enhance spermatogenesis in boars (Deaver and
Bryan, 1999). Our assessment of total spermatozoa per ejaculate in these stallions indicated no
difference between treatments. Administration of GH to castrated mice did not affect accessory
sex gland weights (Keenan and Thomas, 1975). The increases in volume of gel-free semen and
gel in the stallions in this experiment may indicate a long-term effect on accessory sex gland
activity. These observations, as well as the possible effect on sexual behavior (decreased time to
ejaculation), deserve further study.
Previous experiments reported the existence of mammosomatotropes, cells staining for
both prolactin and growth hormone, in the equine pituitary (Rahmanian et al., 1997). Therefore,
frequent sampling periods were conducted around TRH administration to analyze the effects of a
possible concurrent inhibition of prolactin and GH in response to prior exogenous GH treatment
(Smith et al., 1999). In both groups, administration of TRH resulted in an immediate increase in
plasma prolactin concentrations at both high and low doses. This is consistent with previous
reports on TRH administration (Gentry et al., 2002). However, the similarity in response
exhibited between the two groups is contradictory to a concurrent inhibition of prolactin and GH
at the mammosomatotropes. These data suggest that the mechanism controlling prolactin
response to TRH is unassociated with the inhibition of endogenous GH concentrations following
administration of exogenous GH administration.
In summary, no direct effect of exogenous GH administration on plasma concentrations
of LH, FSH, and testosterone in the stallion were observed under the present experimental
design. Furthermore, GH treatment did not affect the ability of TRH to stimulate plasma
concentrations of prolactin. Therefore, the possible role of GH in maintenance of reproduction
in the stallion may be confined to a long-term increase in the activity of the accessory sex glands.
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CHAPTER III
EFFECTS OF MELATONIN TREATMENT ON HORMONAL AND SEMINAL
CHARACTERISTICS IN STALLIONS

Introduction
One of the main goals in equine science is to manipulate the seasonal reproduction of the
horse. Photoperiod was discovered to be a key player in the reproductive recrudescence in the
horse. Increased daily light exposure has been shown to hasten the onset of the ovulatory season
in pony mares (Sharp and Ginther, 1975) and increase mean LH and testosterone levels in
stallions (Thompson et al., 1977). In elucidating the mechanism for photoperiod as a seasonal
regulatory stimulus, the hormone melatonin became implicated as a link between neural and
endocrine pathways. Melatonin secretion by the equine pineal gland is circadian in nature with
elevated levels occurring during the night (Kilmer et al., 1982; Sharp, 1982). As recognition of
the relationship between photoperiod and melatonin secretion progressed, the potential for
melatonin mediation of the reproductive seasonality in the horse became evident. Subsequently,
exogenous melatonin administration was shown to decrease plasma testosterone concentrations
in the stallion (Argo et al., 1991) and alter the chronologic events of the breeding season in the
mare (Peltier et al., 1997). Furthermore, melatonin receptor characterization within the equine
pituitary indicates a possible direct interaction of melatonin at the hypothalamic-hypophyseal
axis (Stankov et al., 1991). There is still much to learn about the involvement of melatonin as a
mediator of seasonality in the horse. The present experiment was designed to assess the effects
of an imposed regimen of melatonin that mimics the short days of winter on plasma
concentrations of prolactin, the response of testosterone to exogenous LH, and the response of
LH and FSH to exogenous GnRH in the stallion.
Materials and Methods
Nine adult, light horse stallions were used in this experiment. All stallions were
maintained in similar outdoor paddocks and fed daily grain and hay rations. Stallions were
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randomly assigned to melatonin treated (n = 5) or control (n = 4) groups. Beginning in July, all
stallions were given 400 g sweet feed at 1400 daily for 90 d with treated stallions receiving
melatonin (0.06 mg/kg BW) in 5 ml corn syrup top-dressing and controls receiving corn syrup
top-dressing alone. Blood samples were taken twice weekly 30 min prior to treatment via
jugular venipuncture into heparinized tubes with two consecutive daily samples taken prior to the
initiation of treatment. On d 2 of treatment, frequent blood samples were collected from all
stallions hourly for 24 h starting at 0800, and at 30 min intervals for the first 2 h following
melatonin treatment to characterize the plasma hormone concentrations in response to oral
melatonin administration. Low dose (0.2 µg/kg BW i.v.) and high dose (0.3 µg/kg BW i.v.) LH
injections were administered to all stallions on d 68 and 73 respectively. Also, low dose (0.1 µg
GnRH and 0.4 µg TRH/kg BW i.v.) and high dose (1.0 µg GnRH and 4.0 µg TRH/kg BW i.v)
GnRH/TRH combination injections were administered on d 70 and 75, respectively. Frequent
blood samples were collected around secretagogue infusions via indwelling jugular catheter into
heparinized tubes at -20, -10, 0, 10, 20, 30, 45, 60, 90, 120, 150, 180, 210, and 240 min relative
to treatment..
On d 83, 84, and 85 of melatonin treatment, semen was collected from all stallions via
artificial vagina and was evaluated for total volume, volume of gel, gel-free volume,
concentration of spermatozoa per ml of gel-free volume, time until ejaculation, and number of
mounts.
Blood collected during frequent and daily sampling was immediately centrifuged, and
plasma was extracted and stored at -15°C until assay. All samples were analyzed by
radioimmunoassay as previously described for LH (Thompson et al., 1983a), FSH (Thompson et
al., 1983b), prolactin (Colborn et al., 1991), and testosterone (Diagnostic Systems Laboratories,
Webster, TX).
Data were analyzed using the GLM procedures of SAS (SAS Inst. Inc., Cary, NC).
Daily hormonal concentrations were analyzed by split-plot ANOVA (Gill and Hafs, 1971) for
the effects of treatment, day, and treatment by day interactions. Hormonal concentration data
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from the period of frequent sampling and around the challenges were analyzed by ANOVA (Gill
and Hafs, 1971) for the effects of treatment, minute, and treatment by minute interactions. Data
at the seminal collections were also evaluated by split-plot ANOVA (Gill and Hafs, 1971) for the
effects of treatment, day, and treatment by day interactions.
Results
Hormonal Data. Treatment with melatonin decreased (P < 0.001) daily plasma
concentrations of prolactin (Figure 3.1). Also, prolactin levels decreased (P < 0.05) over time in
both groups as expected with the change in season. Melatonin treated stallions exhibited
decreased (P < 0.05) prolactin response to the high dose combination of GnRH and TRH (Figure
3.2), yet there was no difference (P > 0.05) in the prolactin response between groups to the
combination injection at the low dose. In both challenges, however, there was an increase (P <
0.001) in plasma prolactin concentrations over time.
Plasma concentrations of LH and FSH in daily samples decreased over time (P < 0.001)
as expected with the change in season (Figure 3.3). Treatment with melatonin did not affect (P >
0.05) daily LH plasma concentrations over the 90-d period, however the plasma LH
concentrations tended to be greater in control stallions (P = 0.07) during the first 30 d of
treatment. After the initial 30-d suppression, the plasma concentrations of LH regained
similarity between groups. Conversely, melatonin treatment was coincident with a significant
decline (P < 0.001) in daily plasma concentrations of FSH. Administration of the high and low
dose combination injections of GnRH and TRH increased (P < 0.001) plasma concentrations of
LH and FSH (Figure 3.4). Melatonin treatment altered (P < 0.001) the response in plasma FSH
concentrations to the low dose GnRH/TRH combination injection, yet the responses in plasma
FSH concentrations at the high dose GnRH/TRH injection were similar (P > 0.05) for the two
groups. No treatment by time interaction (P > 0.05) was observed for LH plasma concentrations
at the high dose GnRH injection, yet plasma LH concentrations tended to be higher (P < 0.1) in
control stallions during the low dose administration of GnRH.
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Figure 3.1. Mean plasma concentrations of prolactin in biweekly blood samples collected from
melatonin (M) treated and control stallions. There was a treatment by time interaction (P <
0.05). The least significant difference (LSD) for comparison of means is indicated by the
vertical bar.
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Figure 3.2. Mean plasma concentrations of prolactin in melatonin (M) treated and control
stallions in response to low (top) and high (bottom) doses of a combined injection of GnRH and
TRH at time 0. There was a treatment by time interaction (P < 0.05) at the high dose
administration. The least significant difference (LSD) for comparison of means is indicated by
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Figure 3.3. Mean plasma concentrations of FSH and LH in biweekly blood samples collected
from melatonin (M) treated and control stallions. There was a treatment by time interaction (P <
0.001) for FSH and treatment by time interaction (P < 0.1) during the first 30 d for LH. The least
significant difference (LSD) for comparison of means is indicated by the vertical bar.
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Figure 3.4. Mean plasma concentrations of FSH and LH in melatonin (M) treated and control
stallions in response to low and high doses of GnRH at time 0. There was a treatment by time
interaction (P < 0.001) at the low dose for FSH. The least significant difference (LSD) for
comparison of means is indicated by the vertical bar.
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Daily plasma testosterone concentrations decreased over time (P < 0.001) in the two
groups (Figure 3.5), but the decline in plasma testosterone concentrations was similar (P > 0.05)
for both groups. Administration of scretogogues at all four frequent sampling periods increased
(P < 0.001) plasma testosterone concentrations in the two groups (Figure 3.6). The testosterone
response to the low dose GnRH administration was decreased (P < 0.001) in melatonin treated
stallions, but there was no difference (P > 0.05) in the response between groups to other low and
high dose secretagogue administrations.
Collection Data. Semen collected on d 83, 84, and 85 did not differ (P > 0.1) in total
volume, volume of gel, gel-free volume, and concentration of spermatozoa per ml of gel-free
volume. Also, time until ejaculation and number of mounts were similar (P > 0.1) between
groups (Table 3.1).
Discussion
Exogenous melatonin administration has been reported to decrease plasma testosterone
concentrations in the stallion (Argo et al., 1991). This is contrary to our results in which similar
treatment with melatonin failed to reduce plasma testosterone levels. Perhaps this lack of
perturbation is due to administration of melatonin during a period of the year in which
testosterone levels are naturally falling (Johnson and Thompson, 1983), such that a melatonin
induced decrease in plasma testosterone concentrations was coincident with the naturally
occurring seasonal decline in testosterone levels. Furthermore, plasma testosterone
concentrations were similar for treated and control stallions after administration of both low and
high dose LH injections. This suggests that the sensitivity of the Leydig cells to stimulation by
LH was not altered by treatment with melatonin. However, the response in plasma testosterone
concentrations for the melatonin treated stallions to the low dose GnRH injection was less than
that of control stallions. This diminished response in testosterone concentrations observed in the
treated stallions after the low dose GnRH injection was coincident with a reduced response in
plasma FSH concentrations and a tendency for lower plasma LH concentrations. Hence,
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Figure 3.5. Mean plasma concentrations of testosterone in biweekly samples collected from
melatonin (M) treated and control stallions. No effect of treatment (P > 0.1) was observed. The
least significant difference (LSD) for comparison of means is indicated by the vertical bar.
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Figure 3.6. Mean plasma concentrations testosterone in melatonin (M) treated and control
stallions in response to low and high doses of GnRH (top) or LH (bottom) administered at time
0. There was a treatment by time interaction (P < 0.001) at the low dose GnRH administration.
The least significant difference (LSD) for comparison of means is indicated by the vertical bar.
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Table 3.1 Semen collection data for control and melatonin treated stallions expressed
as mean ± SEM.
Control
Melatonin
Number of Mounts

1.3 +/- 0.28

1.5 +/- 0.25

51 +/- 7.1

54 +/- 6.4

Gel Volume, ml

10.7 +/- 5.0

11.1 +/- 4.4

Concentration, millions/ml

1.6 +/- 0.5

1.5 +/- 0.4

Total Sperm/Ejaculate,
billions
Motility, %

7.4 +/- 0.88

7.4 +/- 0.78

64 +/- 2.7

61 +/- 2.4

Erection time, min

0.67 +/- 0.35

1.5 +/- 0.31

Gel-Free Volume, ml
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melatonin treatment possibly decreased the sensitivity of the pituitary to stimulation by GnRH,
subsequently resulting in a lessening of the response in plasma testosterone concentrations. In
contrast, administration of melatonin did not alter the testosterone response to the high dose
GnRH administration. This is not in agreement with the melatonin interaction at the low dose
GnRH administration, but may have resulted from overwhelming the hypothalamic pituitary axis
with supraphysiological levels of GnRH.
The short days of winter, when melatonin concentrations are high for the longest duration
each day, have been correlated to decreased plasma concentrations of LH and FSH in long-day
breeders such as the hamster (Reiter, 1981) and the horse (Irvine and Alexander, 1982; Johnson
and Thompson 1983; Clay and Clay, 1992). Similarly, plasma concentrations of LH and FSH in
these stallions decreased with the onset of the autumnal transition. Moreover, melatonin treated
stallions experienced an accelerated decline in plasma concentrations of FSH almost
immediately after administration of melatonin began. Plasma LH concentrations in treated
stallions also tended to fall below controls, however, by d 35 of melatonin administration, LH
concentrations in both treated and control stallions had begun to converge. This precipitous
decline in gonadotropin concentrations immediately after the initiation of melatonin
administration is evidence of a possible role of melatonin in inhibition of GnRH pulse frequency
or a reduction of GnRH receptors on the gonadotropes. The response in plasma concentrations
of LH and FSH to a high dose of GnRH was not altered by melatonin treatment. This was not
the case, however, for the low dose administration of GnRH. Melatonin-treated stallions
exhibited a diminished response in plasma FSH concentrations and tended to have lower
concentrations of LH in samples collected around the low dose GnRH administration. The
absence of perturbation by melatonin treatment on the gonadotropins at the high dose GnRH
administration may be due to an overwhelming of the hypothalamic pituitary axis by introducing
supraphysiological levels of GnRH, such that the subtle differences observed at the low dose
administration were not apparent. The responses exhibited in conjunction with the low dose
administration of GnRH may further indicate an interaction of melatonin at the level of the
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pituitary. Evidence that melatonin may interact at the pituitary has also been established by
localization of melatonin receptors in the equine pituitary (Nonno at el., 1995). Certainly, other
possibilities exist considering the similarity in gonadotropin concentrations at the high dose
administration of GnRH.
In accordance with previous reports (Johnson, 1986; Thompson and Johnson, 1987),
plasma concentrations of prolactin decreased in control stallions with the onset of the autumnal
transition. Melatonin has been reported to decrease plasma concentrations of prolactin in the
mare (Fitzgerald et al., 2000). Correspondingly, melatonin administration hastened the decline
of plasma prolactin concentrations in treated stallions, though the two groups began to converge
by d 60 of treatment. Plasma concentrations of prolactin increased in response to both low and
high dose administrations of TRH, similar to previous reports (Gentry et al., 2002). In addition,
melatonin-treated stallions exhibited a diminished response to the high dose TRH administration,
however plasma concentrations of prolactin at the low dose administration of TRH were similar
for the two groups. Evidently, melatonin administration was not effective at suppressing the
prolactin response to the low dose administration of TRH, but the prolactin secretion required at
the high dose TRH administration was physiologically unattainable by the treated stallions. This
may indicate that the prolactin axis is impeded by the short days of winter not only by a longterm suppression of plasma concentrations of prolactin, but also by inhibiting the prolactin
response to hypothalamic stimulation by TRH.
Prolactin has been implicated in regulation of seminal volume in the horse (Thomson et
al., 1996), and FSH participates in the maintenance of spermatogenesis in the rat (Hadley, 2000).
However, the decreased plasma concentrations of prolactin and FSH in the treated stallions did
not alter the total volume, gel-free volume, or concentration of spermatozoa per ml of gel-free
volume. Perhaps, a more demanding collection regimen may have helped reveal variation
between treatment groups. Time until ejaculation and number of mounts were also similar
between groups, indicating melatonin administration did not inhibit libido. Ejaculates were
collected during the fall, the period when the natural decline in reproductive capacity occurs
38

(Pickett et al., 1976; Thompson et al., 1977; Clay et al., 1987). Therefore, the control stallions
were beginning to exhibit a decline in reproductive status along with the treated stallions. This
was also evident in the daily hormone profiles in treated stallions for LH, FSH, and prolactin
concentrations, all of which became similar to control levels by d 60. Therefore, the ejaculates
on d 83, 84, and 85 may have been collected too far into the autumnal transition to assess
differences due to melatonin treatment.
In summary, melatonin has been previously reported to alter the reproductive status in
various species (Reiter, 1981). In this experiment, long-term melatonin administration decreased
plasma concentrations of prolactin and FSH. The effect of melatonin on plasma concentrations
of LH was less evident, and plasma concentrations of testosterone were not altered. While the
effects of melatonin on the basal levels of these pituitary hormones was evident, the role in
which melatonin interacts within the hypothalamic pituitary axis to modify these hormones was
not clearly established by our experimental design. It seems plausible, given the decreased
responses observed in plasma concentrations of FSH and prolactin to administration of the
combined injections of GnRH and TRH, that some inhibitory role of melatonin in the
hypothalamic regulation of the pituitary exists.
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CONCLUSIONS
Administration of recombinant equine GH was previously found to increase follicle
numbers and ovulation rates in mares by possibly increasing the number of LH receptors present
on the ovaries (Cochran et al., 2000, 1999a,b). In the first experiment, effects of similar
treatment with recombinant equine GH on the testicular sensitivity of the stallion was studied,
anticipating that the GH administration would increase the sensitivity of the Leydig cells by
possibly up-regulating the number of receptors for LH. Therefore, treated stallions would
exhibit a greater testosterone response to subsequent administration of LH. Daily administration
of GH to the stallion did not alter the response in plasma testosterone concentrations after
administration of LH or GnRH. Thus, GH treatment in the stallion apparently does not increase
the sensitivity of the Leydig cells to stimulation by LH. However, when stallions were collected
60 d after the initiation of GH treatment, treated stallions had increased seminal volume and
libido. Furthermore, GH treatment did not affect the ability of TRH to stimulate plasma
concentrations of prolactin. Therefore, the role of GH in maintenance of reproduction in the
stallion may be confined to a long-term increase in the activity of the accessory sex glands.
In the second experiment, long-term melatonin administration decreased plasma
concentrations of prolactin and FSH. However, the effect of melatonin on plasma concentrations
of LH was less evident, and plasma concentrations of testosterone were not altered. Melatonin
perturbation of the basal levels of these pituitary hormones was evident. However, the role in
which melatonin interacts within the hypothalamic pituitary axis to modify these hormones was
not clearly established by our experimental design. It seems plausible, given the decreased
responses observed in plasma concentrations of FSH and prolactin to administration of the
combined injections of GnRH and TRH, that some inhibitory role of melatonin in hypothalamic
regulation of the pituitary exists.
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